Last reviewed · How we verify
COVID-19 Standard Treatment
COVID-19 Standard Treatment is a Small molecule drug developed by Dermama Bioteknologi Laboratorium. It is currently in Phase 2 development for Prevention of COVID-19 disease. Also known as: Drugs accepted as cures for COVID-19.
This drug targets the SARS-CoV-2 virus to prevent COVID-19 infection.
This drug targets the SARS-CoV-2 virus to prevent COVID-19 infection. Used for Prevention of COVID-19 disease.
At a glance
| Generic name | COVID-19 Standard Treatment |
|---|---|
| Also known as | Drugs accepted as cures for COVID-19 |
| Sponsor | Dermama Bioteknologi Laboratorium |
| Target | SARS-CoV-2 spike protein |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of action is not fully understood, but it is believed to work by binding to the spike protein of the SARS-CoV-2 virus, preventing it from entering host cells.
Approved indications
- Prevention of COVID-19 disease
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (PHASE2)
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma (EARLY_PHASE1)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (PHASE2)
- Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients (NA)
- COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II) (PHASE2)
- Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia (PHASE3)
- The Tele-Rehab MV Cluster Stepped-Wedge Randomized Clinical Trial (NA)
- Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- COVID-19 Standard Treatment CI brief — competitive landscape report
- COVID-19 Standard Treatment updates RSS · CI watch RSS
- Dermama Bioteknologi Laboratorium portfolio CI
Frequently asked questions about COVID-19 Standard Treatment
What is COVID-19 Standard Treatment?
How does COVID-19 Standard Treatment work?
What is COVID-19 Standard Treatment used for?
Who makes COVID-19 Standard Treatment?
Is COVID-19 Standard Treatment also known as anything else?
What development phase is COVID-19 Standard Treatment in?
What are the side effects of COVID-19 Standard Treatment?
What does COVID-19 Standard Treatment target?
Related
- Target: All drugs targeting SARS-CoV-2 spike protein
- Manufacturer: Dermama Bioteknologi Laboratorium — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Prevention of COVID-19 disease
- Also known as: Drugs accepted as cures for COVID-19
- Compare: COVID-19 Standard Treatment vs similar drugs
- Pricing: COVID-19 Standard Treatment cost, discount & access